MedTrace Logo

Seattle-PAP Bubble Nasal CPAP and Work of Breathing

NCT02210026 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-04-14

No results posted yet for this study

Summary

The investigators propose to test the hypothesis that Seattle bubble nasal continuous positive airway pressure (Seattle-PAP) supports respiratory physiology in very low birth weight (VLBW) infants more effectively than standard bubble nasal continuous positive airway pressure.

Conditions

  • Respiratory Distress Syndrome In Premature Infants
  • Bronchopulmonary Dysplasia
  • Newborn Primary Sleep Apnea

Interventions

DEVICE

Seattle-PAP

We propose to test the hypothesis that by introduction of variation in airway pressure Seattle bubble nasal continuous positive airway pressure (Seattle-PAP) reduces work of breathing in very low birth weight infants more effectively than standard bubble nasal continuous positive airway pressure.

Sponsors & Collaborators

  • Baylor College of Medicine

    collaborator OTHER

  • Seattle Children's Hospital

    lead OTHER

Principal Investigators

  • Charles V Smith, PhD · Seattle Children's Hospital

  • Stephen E Welty, MD · Baylor College of Medicine

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Hours
Max Age
72 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02210026 on ClinicalTrials.gov